Brain Stimulation Paired With Structured Language Learning in Adults
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorGeneral Neuro Inc.
About this trial
This study investigates whether transcranial electrical stimulation (tES) delivered during structured language-learning sessions affects the rate and quality of second-language acquisition in adults.
Adults who are learning or planning to learn a new language are randomly assigned in equal numbers to receive either active stimulation or sham (placebo) stimulation while completing structured language-learning content. Participants wear a non-invasive transcranial electrical stimulation headset that delivers a low-level electrical current through electrodes resting on the scalp, targeting cortical regions associated with language. Sessions typically last 20 to 30 minutes and may be completed at home or in person at a participating language program.
Language proficiency is measured with a standardized assessment before and after the intervention period, with additional app-derived performance metrics and participant-reported measures collected throughout. A follow-up assessment may be conducted up to 12 months after the intervention ends to evaluate whether any observed effects persist.
In this study the device is applied as a learning aid in healthy adults. It is not used to diagnose, treat, cure, or prevent any disease.
Eligibility criteria
Qualifiers
Adults aged 18 years or older
Able to understand the consent materials and the informed consent process in English, or in another language for which an IRB-approved consent form is available
Willing and able to participate in structured language-learning activities for the duration of the intervention period
Able to provide written informed consent
Disqualifiers
History of epilepsy or any seizure disorder
Active skin disease, open wounds, or significant skin irritation at electrode contact sites
Implanted electronic medical devices where stimulation would be contraindicated per device manufacturer guidance or investigator judgment after individual risk assessment
Significant cognitive impairment that would interfere with informed consent or study participation
Trial design
Treatments tested in this trial
- Active transcranial electrical stimulation (tES)
- Sham transcranial electrical stimulation (tES)
Treatment groups
60 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov